Key facts
- Notable investors include Vesna Deep Tech Fund, ABHI US Accelerator, Accelerating FemTech, DigitalHealth.London Accelerator.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Megi Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Megi Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Megi Health
Developer of a digital health platform designed for personalized cardiovascular care for women across key life stages. The company's platform uses proprietary artificial intelligence (AI) models and longitudinal clinical data to identify early risks of preeclampsia, monitor maternal health during the postpartum period, and support long-term heart health, enabling healthcare providers to detect complications earlier, address the maternal health care gap, and deliver structured cardiovascular care beyond pregnancy.
- Sector
- Healthcare
- HQ
- Chicago, IL, United States
- Founded
- 2022
- Employees
- 13
- Website
- megi.ai/
- Ownership
- Privately Held (backing)
Megi Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Megi Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Megi Health in its N-PORT filings yet. We sweep new filings monthly.